KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) EBITDA (2016 - 2026)

Encompass Health (EHC) has disclosed EBITDA for 18 consecutive years, with $59.7 million as the latest value for Q1 2026.

  • For Q1 2026, EBITDA fell 69.62% year-over-year to $59.7 million; the TTM value through Mar 2026 reached -$147.2 million, down 122.5%, while the annual FY2025 figure was $438.3 million, 26.53% down from the prior year.
  • EBITDA hit $59.7 million in Q1 2026 for Encompass Health, up from -$415.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $196.5 million in Q1 2025 and bottomed at -$415.4 million in Q4 2025.
  • Average EBITDA over 5 years is $86.2 million, with a median of $113.4 million recorded in 2023.
  • Year-over-year, EBITDA surged 149.78% in 2023 and then tumbled 352.98% in 2025.
  • Encompass Health's EBITDA stood at $184.3 million in 2022, then tumbled by 52.47% to $87.6 million in 2023, then surged by 87.44% to $164.2 million in 2024, then crashed by 352.98% to -$415.4 million in 2025, then soared by 114.37% to $59.7 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods came in at $59.7 million, -$415.4 million, and $12.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.